Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
Date:4/21/2008

CONFERENCE CALL AND WEBCAST SCHEDULED FOR WEDNESDAY, APRIL 30

SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2008 financial results after the Nasdaq market closes on Wednesday, April 30, 2008. Neurocrine will host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, April 30, 2008 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 1-800-895-1715 (US) or 785-424-1059 (International) using the conference ID: 7NBIX1. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-753-9146 (US) or 402-220-2705 (International) using the conference ID: 7NBIX1. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
2. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
3. Neurocrine Announces Work Force Restructuring
4. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
5. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
6. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
8. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
9. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
10. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
11. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 /PRNewswire/ ... to grow at a CAGR of around 7.5% ... billion by 2025. Some of the prominent trends ... population, growing incidences of diseases & graft transplant ... Based on Material the market is categorized into ...
(Date:1/17/2017)... 17, 2017 Noom Inc. , ... first to offer fully Spanish behavior change programs ... Spanish diabetes prevention and healthy weight management ... of lifestyle interventions among Hispanic Americans who are ... robust food database, program-specific curriculum content and program ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body ... lifestyle, announced today the official launch of its much-anticipated Pono Board: a re-invented fitness ... , In development for over a year, the patented Pono Board is the world’s ...
(Date:1/17/2017)... , Jan. 17, 2017  On January 10 ... 35th Annual J.P. Morgan Healthcare Conference in ... D. Kittle, Jr. , spoke to pharmaceutical leaders and ... by ProclaRx to break down and destroy biofilms.  ... bacteria and prevent antibiotics and the body,s immune system ...
Breaking Biology Technology:
(Date:12/16/2016)... The global wearable medical device market, in terms of value, is ... billion in 2016, at a CAGR of 18.0% during the forecast ... Growth ... devices, launch of a growing number of smartphone-based healthcare apps compatible ... and increasing focus on physical fitness. Furthermore, growing ...
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the addition ... offering. The report forecasts the global military biometrics market ... The report has been prepared based on an in-depth market ... and its growth prospects over the coming years. The report also includes ...
(Date:12/15/2016)... -- "Increase in mobile transactions is driving the growth ... is expected to grow from USD 4.03 billion in ... CAGR of 29.3% between 2016 and 2022. The market ... for smart devices, government initiatives, and increasing penetration of ... expected to grow at a high rate during the ...
Breaking Biology News(10 mins):